

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.85047026 |
| 2 | platelet dense granule organization (GO:0060155) | 4.55948929 |
| 3 | iron-sulfur cluster assembly (GO:0016226) | 4.40113199 |
| 4 | metallo-sulfur cluster assembly (GO:0031163) | 4.40113199 |
| 5 | protein-cofactor linkage (GO:0018065) | 4.32621975 |
| 6 | positive regulation of mitochondrial fission (GO:0090141) | 4.11697514 |
| 7 | protein complex biogenesis (GO:0070271) | 4.05250297 |
| 8 | sequestering of actin monomers (GO:0042989) | 4.01371708 |
| 9 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.90796527 |
| 10 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.88453217 |
| 11 | NADH dehydrogenase complex assembly (GO:0010257) | 3.88453217 |
| 12 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.88453217 |
| 13 | proteasome assembly (GO:0043248) | 3.86818885 |
| 14 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.82025138 |
| 15 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.82025138 |
| 16 | mannosylation (GO:0097502) | 3.77125394 |
| 17 | GPI anchor metabolic process (GO:0006505) | 3.74231152 |
| 18 | base-excision repair, AP site formation (GO:0006285) | 3.73484181 |
| 19 | protein neddylation (GO:0045116) | 3.72749275 |
| 20 | cytidine deamination (GO:0009972) | 3.72124134 |
| 21 | cytidine metabolic process (GO:0046087) | 3.72124134 |
| 22 | cytidine catabolic process (GO:0006216) | 3.72124134 |
| 23 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.66883121 |
| 24 | GPI anchor biosynthetic process (GO:0006506) | 3.62804813 |
| 25 | ATP synthesis coupled proton transport (GO:0015986) | 3.59482568 |
| 26 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.59482568 |
| 27 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.58685502 |
| 28 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.57128526 |
| 29 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.50194899 |
| 30 | actin nucleation (GO:0045010) | 3.44379066 |
| 31 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.43139703 |
| 32 | respiratory electron transport chain (GO:0022904) | 3.28214153 |
| 33 | electron transport chain (GO:0022900) | 3.25026023 |
| 34 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.24789158 |
| 35 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.22474902 |
| 36 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.19051593 |
| 37 | respiratory chain complex IV assembly (GO:0008535) | 3.17283551 |
| 38 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.08438148 |
| 39 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.06579672 |
| 40 | protein deneddylation (GO:0000338) | 3.05083223 |
| 41 | C-terminal protein lipidation (GO:0006501) | 3.04800283 |
| 42 | chaperone-mediated protein transport (GO:0072321) | 3.00340295 |
| 43 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.00032172 |
| 44 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.98718131 |
| 45 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.97775663 |
| 46 | cullin deneddylation (GO:0010388) | 2.94700825 |
| 47 | regulation of mitochondrial fission (GO:0090140) | 2.94121149 |
| 48 | deoxyribonucleotide catabolic process (GO:0009264) | 2.92621258 |
| 49 | C-terminal protein amino acid modification (GO:0018410) | 2.85544480 |
| 50 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.83908808 |
| 51 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.83607267 |
| 52 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.83607267 |
| 53 | L-methionine salvage (GO:0071267) | 2.78103515 |
| 54 | L-methionine biosynthetic process (GO:0071265) | 2.78103515 |
| 55 | amino acid salvage (GO:0043102) | 2.78103515 |
| 56 | hydrogen ion transmembrane transport (GO:1902600) | 2.76414140 |
| 57 | deoxyribose phosphate catabolic process (GO:0046386) | 2.75685631 |
| 58 | proton transport (GO:0015992) | 2.75102382 |
| 59 | negative regulation of telomere maintenance (GO:0032205) | 2.73465605 |
| 60 | cytochrome complex assembly (GO:0017004) | 2.72300104 |
| 61 | hydrogen transport (GO:0006818) | 2.71676777 |
| 62 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.69801687 |
| 63 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.69801687 |
| 64 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.69801687 |
| 65 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.68351161 |
| 66 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.68351161 |
| 67 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.67398020 |
| 68 | anterograde synaptic vesicle transport (GO:0048490) | 2.66671142 |
| 69 | adenosine metabolic process (GO:0046085) | 2.63265160 |
| 70 | glycolipid biosynthetic process (GO:0009247) | 2.62082785 |
| 71 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.58042063 |
| 72 | ubiquinone biosynthetic process (GO:0006744) | 2.57984834 |
| 73 | piRNA metabolic process (GO:0034587) | 2.56930858 |
| 74 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.56425553 |
| 75 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.54892900 |
| 76 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.54033771 |
| 77 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.53267207 |
| 78 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.52375320 |
| 79 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.52375320 |
| 80 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.50754607 |
| 81 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.50522791 |
| 82 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.49431131 |
| 83 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.49206262 |
| 84 | negative regulation of mast cell activation (GO:0033004) | 2.48733255 |
| 85 | response to pheromone (GO:0019236) | 2.46880016 |
| 86 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.46010262 |
| 87 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.43612399 |
| 88 | termination of RNA polymerase III transcription (GO:0006386) | 2.43612399 |
| 89 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.43351385 |
| 90 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.42659102 |
| 91 | peptidyl-histidine modification (GO:0018202) | 2.40019016 |
| 92 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.39705066 |
| 93 | ubiquinone metabolic process (GO:0006743) | 2.39102689 |
| 94 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.39084237 |
| 95 | peroxisome fission (GO:0016559) | 2.38806949 |
| 96 | negative regulation of membrane potential (GO:0045837) | 2.37684924 |
| 97 | tRNA processing (GO:0008033) | 2.37460598 |
| 98 | protein localization to cilium (GO:0061512) | 2.37338097 |
| 99 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.37221968 |
| 100 | positive regulation of prostaglandin secretion (GO:0032308) | 2.36459011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.17684744 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.94081183 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.78185531 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.64558262 |
| 5 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.21049832 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.08335330 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.06563610 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.03440669 |
| 9 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.92561858 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.70732636 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.58665612 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.52548814 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.52378373 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.46366761 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.18848018 |
| 16 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.16995956 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.16743223 |
| 18 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.13859664 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.13106671 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.08770811 |
| 21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.07764726 |
| 22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.05884996 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.95105944 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 1.84151499 |
| 25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.83876092 |
| 26 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.82668964 |
| 27 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80142803 |
| 28 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.73031730 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.66777398 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65445643 |
| 31 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.64469068 |
| 32 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.61326188 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.56832868 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.55101494 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53202330 |
| 36 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.52281140 |
| 37 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.51633757 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.51251201 |
| 39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.49482842 |
| 40 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.44508115 |
| 41 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.44038164 |
| 42 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42173272 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.42136109 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40819977 |
| 45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.35720352 |
| 46 | GATA3_26560356_Chip-Seq_TH2_Human | 1.34932924 |
| 47 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.34159972 |
| 48 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.32069602 |
| 49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27935790 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.27559724 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.24223311 |
| 52 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.23874860 |
| 53 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.23874860 |
| 54 | AR_20517297_ChIP-Seq_VCAP_Human | 1.18236720 |
| 55 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.17800454 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.15506266 |
| 57 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14020508 |
| 58 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13004971 |
| 59 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.12888705 |
| 60 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11585216 |
| 61 | NCOR_22424771_ChIP-Seq_293T_Human | 1.11056390 |
| 62 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.10957361 |
| 63 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10808797 |
| 64 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.10421982 |
| 65 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.09024290 |
| 66 | EWS_26573619_Chip-Seq_HEK293_Human | 1.08552473 |
| 67 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07542634 |
| 68 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.04990435 |
| 69 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.04046042 |
| 70 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.03774576 |
| 71 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03624352 |
| 72 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03504430 |
| 73 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.02858296 |
| 74 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01257376 |
| 75 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.00980794 |
| 76 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00696196 |
| 77 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99364726 |
| 78 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98898297 |
| 79 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98898297 |
| 80 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98797940 |
| 81 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.97760497 |
| 82 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97198208 |
| 83 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.96751502 |
| 84 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.96345729 |
| 85 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95736042 |
| 86 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.95300665 |
| 87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95132139 |
| 88 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.94878703 |
| 89 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.94247740 |
| 90 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94035930 |
| 91 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94021200 |
| 92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93954569 |
| 93 | * MYB_26560356_Chip-Seq_TH2_Human | 0.93276106 |
| 94 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92182114 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.91740030 |
| 96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.91740030 |
| 97 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.91663298 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91245409 |
| 99 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.90599455 |
| 100 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.89567935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 3.23896545 |
| 2 | MP0004147_increased_porphyrin_level | 3.12540985 |
| 3 | MP0002102_abnormal_ear_morphology | 3.00333319 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.60364800 |
| 5 | MP0006072_abnormal_retinal_apoptosis | 2.35858584 |
| 6 | MP0001529_abnormal_vocalization | 2.31164396 |
| 7 | MP0005645_abnormal_hypothalamus_physiol | 2.28441617 |
| 8 | MP0009785_altered_susceptibility_to | 2.11279442 |
| 9 | MP0008877_abnormal_DNA_methylation | 2.10798589 |
| 10 | MP0005084_abnormal_gallbladder_morpholo | 2.01990849 |
| 11 | MP0008995_early_reproductive_senescence | 1.97550711 |
| 12 | MP0001905_abnormal_dopamine_level | 1.95212967 |
| 13 | MP0003724_increased_susceptibility_to | 1.92305492 |
| 14 | MP0002653_abnormal_ependyma_morphology | 1.92146125 |
| 15 | MP0006276_abnormal_autonomic_nervous | 1.81074163 |
| 16 | MP0001984_abnormal_olfaction | 1.78501497 |
| 17 | MP0000372_irregular_coat_pigmentation | 1.77754262 |
| 18 | MP0009046_muscle_twitch | 1.73145594 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 1.72553312 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 1.71145489 |
| 21 | MP0005253_abnormal_eye_physiology | 1.70080219 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 1.70068991 |
| 23 | MP0009764_decreased_sensitivity_to | 1.69875409 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.69530097 |
| 25 | MP0001968_abnormal_touch/_nociception | 1.66776511 |
| 26 | MP0003011_delayed_dark_adaptation | 1.64305369 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.61452401 |
| 28 | MP0003786_premature_aging | 1.59805166 |
| 29 | MP0003880_abnormal_central_pattern | 1.57336784 |
| 30 | MP0001986_abnormal_taste_sensitivity | 1.56981196 |
| 31 | MP0004142_abnormal_muscle_tone | 1.55919282 |
| 32 | MP0006035_abnormal_mitochondrial_morpho | 1.51818485 |
| 33 | MP0001800_abnormal_humoral_immune | 1.51125736 |
| 34 | MP0002736_abnormal_nociception_after | 1.48766419 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.46218279 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.44812604 |
| 37 | MP0008872_abnormal_physiological_respon | 1.44436431 |
| 38 | MP0008058_abnormal_DNA_repair | 1.40941194 |
| 39 | MP0002723_abnormal_immune_serum | 1.40838853 |
| 40 | MP0003646_muscle_fatigue | 1.38460090 |
| 41 | MP0003186_abnormal_redox_activity | 1.33953094 |
| 42 | MP0002822_catalepsy | 1.33029303 |
| 43 | MP0008789_abnormal_olfactory_epithelium | 1.32453082 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.29857209 |
| 45 | MP0009745_abnormal_behavioral_response | 1.29729050 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.27310373 |
| 47 | MP0001819_abnormal_immune_cell | 1.24556710 |
| 48 | MP0005394_taste/olfaction_phenotype | 1.24310902 |
| 49 | MP0005499_abnormal_olfactory_system | 1.24310902 |
| 50 | MP0001764_abnormal_homeostasis | 1.23649801 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.23644069 |
| 52 | MP0002277_abnormal_respiratory_mucosa | 1.23156260 |
| 53 | MP0002876_abnormal_thyroid_physiology | 1.21364862 |
| 54 | MP0000516_abnormal_urinary_system | 1.19312446 |
| 55 | MP0005367_renal/urinary_system_phenotyp | 1.19312446 |
| 56 | MP0002272_abnormal_nervous_system | 1.17103432 |
| 57 | MP0003195_calcinosis | 1.14534878 |
| 58 | MP0005025_abnormal_response_to | 1.14481499 |
| 59 | MP0005387_immune_system_phenotype | 1.13350881 |
| 60 | MP0001790_abnormal_immune_system | 1.13350881 |
| 61 | MP0008875_abnormal_xenobiotic_pharmacok | 1.13049292 |
| 62 | MP0000685_abnormal_immune_system | 1.09201770 |
| 63 | MP0003122_maternal_imprinting | 1.08709254 |
| 64 | MP0003787_abnormal_imprinting | 1.00411497 |
| 65 | MP0001501_abnormal_sleep_pattern | 0.96784111 |
| 66 | MP0002234_abnormal_pharynx_morphology | 0.96663369 |
| 67 | MP0001919_abnormal_reproductive_system | 0.95429568 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 0.94740037 |
| 69 | MP0000716_abnormal_immune_system | 0.93467755 |
| 70 | MP0005410_abnormal_fertilization | 0.92618962 |
| 71 | MP0003718_maternal_effect | 0.89160658 |
| 72 | MP0000631_abnormal_neuroendocrine_gland | 0.88573488 |
| 73 | MP0001970_abnormal_pain_threshold | 0.86691945 |
| 74 | MP0002163_abnormal_gland_morphology | 0.85164875 |
| 75 | MP0005379_endocrine/exocrine_gland_phen | 0.85144483 |
| 76 | MP0001845_abnormal_inflammatory_respons | 0.84893576 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 0.84611793 |
| 78 | MP0002733_abnormal_thermal_nociception | 0.83837148 |
| 79 | MP0000689_abnormal_spleen_morphology | 0.83830814 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 0.83557235 |
| 81 | MP0005386_behavior/neurological_phenoty | 0.83005992 |
| 82 | MP0004924_abnormal_behavior | 0.83005992 |
| 83 | MP0009763_increased_sensitivity_to | 0.82756406 |
| 84 | MP0005389_reproductive_system_phenotype | 0.82306301 |
| 85 | MP0002751_abnormal_autonomic_nervous | 0.82306130 |
| 86 | MP0002095_abnormal_skin_pigmentation | 0.81409963 |
| 87 | MP0005332_abnormal_amino_acid | 0.80632783 |
| 88 | MP0003121_genomic_imprinting | 0.80450712 |
| 89 | MP0006082_CNS_inflammation | 0.80108517 |
| 90 | MP0002638_abnormal_pupillary_reflex | 0.79994734 |
| 91 | MP0002419_abnormal_innate_immunity | 0.79891017 |
| 92 | MP0001188_hyperpigmentation | 0.79497794 |
| 93 | MP0001542_abnormal_bone_strength | 0.79311142 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.78836311 |
| 95 | MP0002398_abnormal_bone_marrow | 0.77985275 |
| 96 | MP0003866_abnormal_defecation | 0.77510796 |
| 97 | MP0001502_abnormal_circadian_rhythm | 0.75876130 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.73954415 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 0.73811691 |
| 100 | MP0002735_abnormal_chemical_nociception | 0.73739159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mitochondrial inheritance (HP:0001427) | 4.05225335 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.00554910 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.94242375 |
| 4 | Hepatocellular necrosis (HP:0001404) | 3.93997035 |
| 5 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.91728048 |
| 6 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.91728048 |
| 7 | Increased CSF lactate (HP:0002490) | 3.75651431 |
| 8 | Hepatic necrosis (HP:0002605) | 3.74015042 |
| 9 | 3-Methylglutaconic aciduria (HP:0003535) | 3.71188905 |
| 10 | Acute encephalopathy (HP:0006846) | 3.50367126 |
| 11 | Progressive macrocephaly (HP:0004481) | 3.37951645 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.20974194 |
| 13 | Increased intramyocellular lipid droplets (HP:0012240) | 3.20048168 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.14158770 |
| 15 | Pancreatic cysts (HP:0001737) | 3.06123366 |
| 16 | Renal Fanconi syndrome (HP:0001994) | 2.97125200 |
| 17 | Increased serum lactate (HP:0002151) | 2.85022873 |
| 18 | Lactic acidosis (HP:0003128) | 2.79569068 |
| 19 | Increased muscle lipid content (HP:0009058) | 2.79100597 |
| 20 | Medial flaring of the eyebrow (HP:0010747) | 2.73131545 |
| 21 | IgG deficiency (HP:0004315) | 2.66787017 |
| 22 | Type II lissencephaly (HP:0007260) | 2.66225475 |
| 23 | Abolished electroretinogram (ERG) (HP:0000550) | 2.64852448 |
| 24 | Retinal dysplasia (HP:0007973) | 2.59012969 |
| 25 | Renal cortical cysts (HP:0000803) | 2.56619150 |
| 26 | Type I transferrin isoform profile (HP:0003642) | 2.56496034 |
| 27 | Pancreatic fibrosis (HP:0100732) | 2.55536565 |
| 28 | True hermaphroditism (HP:0010459) | 2.51588774 |
| 29 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.50284555 |
| 30 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.50284555 |
| 31 | Abnormal protein glycosylation (HP:0012346) | 2.50284555 |
| 32 | Abnormal glycosylation (HP:0012345) | 2.50284555 |
| 33 | Generalized aminoaciduria (HP:0002909) | 2.46788771 |
| 34 | Cerebral edema (HP:0002181) | 2.45640519 |
| 35 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.43368842 |
| 36 | Abnormality of midbrain morphology (HP:0002418) | 2.41099277 |
| 37 | Molar tooth sign on MRI (HP:0002419) | 2.41099277 |
| 38 | Hyperglycinemia (HP:0002154) | 2.40927923 |
| 39 | Methylmalonic acidemia (HP:0002912) | 2.36157584 |
| 40 | Congenital stationary night blindness (HP:0007642) | 2.36054688 |
| 41 | Optic disc pallor (HP:0000543) | 2.35418518 |
| 42 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.34965093 |
| 43 | Severe combined immunodeficiency (HP:0004430) | 2.34394839 |
| 44 | Exertional dyspnea (HP:0002875) | 2.34237450 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.32850779 |
| 46 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.32087582 |
| 47 | Lissencephaly (HP:0001339) | 2.28061232 |
| 48 | Stomatitis (HP:0010280) | 2.27888726 |
| 49 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.26899785 |
| 50 | Methylmalonic aciduria (HP:0012120) | 2.26321603 |
| 51 | Congenital primary aphakia (HP:0007707) | 2.21051922 |
| 52 | Gait imbalance (HP:0002141) | 2.20561051 |
| 53 | Aplastic anemia (HP:0001915) | 2.19991562 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.19795680 |
| 55 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.19021175 |
| 56 | Amyotrophic lateral sclerosis (HP:0007354) | 2.14865883 |
| 57 | Respiratory failure (HP:0002878) | 2.13263778 |
| 58 | Nephrogenic diabetes insipidus (HP:0009806) | 2.12454790 |
| 59 | Emotional lability (HP:0000712) | 2.10140052 |
| 60 | Progressive microcephaly (HP:0000253) | 2.08771442 |
| 61 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.08499275 |
| 62 | Abnormality of alanine metabolism (HP:0010916) | 2.08499275 |
| 63 | Hyperalaninemia (HP:0003348) | 2.08499275 |
| 64 | Exercise intolerance (HP:0003546) | 2.06015896 |
| 65 | Polyphagia (HP:0002591) | 2.04993992 |
| 66 | Lethargy (HP:0001254) | 2.04665925 |
| 67 | CNS demyelination (HP:0007305) | 2.03816269 |
| 68 | Increased IgM level (HP:0003496) | 2.01168904 |
| 69 | Abnormality of urine glucose concentration (HP:0011016) | 2.00731779 |
| 70 | Glycosuria (HP:0003076) | 2.00731779 |
| 71 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.97957137 |
| 72 | Dicarboxylic aciduria (HP:0003215) | 1.97957137 |
| 73 | Short tibia (HP:0005736) | 1.97929455 |
| 74 | Hypothermia (HP:0002045) | 1.93500414 |
| 75 | Thyroiditis (HP:0100646) | 1.91686088 |
| 76 | Attenuation of retinal blood vessels (HP:0007843) | 1.90880352 |
| 77 | Abnormality of the renal cortex (HP:0011035) | 1.90789286 |
| 78 | Degeneration of anterior horn cells (HP:0002398) | 1.88361549 |
| 79 | Abnormality of the anterior horn cell (HP:0006802) | 1.88361549 |
| 80 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.88041822 |
| 81 | Sclerocornea (HP:0000647) | 1.86447241 |
| 82 | Abnormality of renal resorption (HP:0011038) | 1.84783610 |
| 83 | Hypoproteinemia (HP:0003075) | 1.83652451 |
| 84 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.82983037 |
| 85 | Abnormality of the prostate (HP:0008775) | 1.81912552 |
| 86 | Abnormality of eosinophils (HP:0001879) | 1.81409949 |
| 87 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.80457762 |
| 88 | Failure to thrive in infancy (HP:0001531) | 1.79480436 |
| 89 | Inability to walk (HP:0002540) | 1.76753251 |
| 90 | Pachygyria (HP:0001302) | 1.76689305 |
| 91 | Progressive inability to walk (HP:0002505) | 1.74448903 |
| 92 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.73410496 |
| 93 | Cerebral palsy (HP:0100021) | 1.72980634 |
| 94 | Pendular nystagmus (HP:0012043) | 1.70487053 |
| 95 | Increased serum pyruvate (HP:0003542) | 1.69976683 |
| 96 | Ketoacidosis (HP:0001993) | 1.69917858 |
| 97 | Nephronophthisis (HP:0000090) | 1.68742585 |
| 98 | Acute hepatic failure (HP:0006554) | 1.68432964 |
| 99 | Ketosis (HP:0001946) | 1.68331810 |
| 100 | Hypoplasia of the uterus (HP:0000013) | 1.66425744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 4.41054361 |
| 2 | MAP4K2 | 4.25657751 |
| 3 | BCKDK | 3.46378914 |
| 4 | TAOK3 | 2.51380497 |
| 5 | TRIM28 | 2.43654205 |
| 6 | TXK | 2.39660443 |
| 7 | BCR | 2.20790290 |
| 8 | KDR | 2.14360048 |
| 9 | ZAK | 2.08440212 |
| 10 | CDK19 | 2.01251638 |
| 11 | CSNK1G3 | 1.98474735 |
| 12 | FRK | 1.95811000 |
| 13 | TLK1 | 1.95719672 |
| 14 | LIMK1 | 1.81182762 |
| 15 | MAP2K7 | 1.79844306 |
| 16 | PINK1 | 1.71145754 |
| 17 | TESK1 | 1.70744816 |
| 18 | WNK3 | 1.70609392 |
| 19 | CSNK1G2 | 1.69123829 |
| 20 | CSNK1A1L | 1.68669223 |
| 21 | ADRBK2 | 1.68548891 |
| 22 | GRK1 | 1.59327502 |
| 23 | NUAK1 | 1.52243331 |
| 24 | VRK2 | 1.48304538 |
| 25 | CSNK1G1 | 1.46997436 |
| 26 | ERBB3 | 1.41685266 |
| 27 | VRK1 | 1.41090694 |
| 28 | MAP3K4 | 1.38181668 |
| 29 | MAPK13 | 1.33613491 |
| 30 | MAP3K12 | 1.31718683 |
| 31 | SRPK1 | 1.31525480 |
| 32 | PIM2 | 1.30693757 |
| 33 | INSRR | 1.24719673 |
| 34 | RPS6KA5 | 1.16365310 |
| 35 | DYRK2 | 1.15419568 |
| 36 | MAP4K1 | 0.96870453 |
| 37 | IKBKB | 0.96557192 |
| 38 | OXSR1 | 0.94649658 |
| 39 | GRK6 | 0.92738388 |
| 40 | EIF2AK3 | 0.90723549 |
| 41 | IKBKE | 0.86741827 |
| 42 | SIK3 | 0.85934558 |
| 43 | STK16 | 0.84351662 |
| 44 | EPHA3 | 0.84051346 |
| 45 | RPS6KA4 | 0.83890160 |
| 46 | SYK | 0.81133544 |
| 47 | DAPK1 | 0.79008564 |
| 48 | CCNB1 | 0.78895080 |
| 49 | TEC | 0.78780987 |
| 50 | DYRK3 | 0.77172346 |
| 51 | TIE1 | 0.76025002 |
| 52 | MAP3K5 | 0.75304953 |
| 53 | BMPR2 | 0.74978025 |
| 54 | TBK1 | 0.74706713 |
| 55 | ITK | 0.74355234 |
| 56 | LYN | 0.72982505 |
| 57 | FES | 0.72629965 |
| 58 | GRK7 | 0.71984742 |
| 59 | MINK1 | 0.70401528 |
| 60 | KIT | 0.70126498 |
| 61 | MARK1 | 0.70035394 |
| 62 | PRKCE | 0.69283808 |
| 63 | PLK2 | 0.68518391 |
| 64 | MST4 | 0.68329789 |
| 65 | FLT3 | 0.66324895 |
| 66 | PRKCQ | 0.63263714 |
| 67 | DAPK2 | 0.62563265 |
| 68 | BMPR1B | 0.61205096 |
| 69 | SCYL2 | 0.60645645 |
| 70 | MAPKAPK3 | 0.60572358 |
| 71 | CSF1R | 0.60106841 |
| 72 | PAK3 | 0.57115117 |
| 73 | ADRBK1 | 0.56665844 |
| 74 | WNK4 | 0.55162883 |
| 75 | MAP3K11 | 0.53712529 |
| 76 | PHKG1 | 0.53627560 |
| 77 | PHKG2 | 0.53627560 |
| 78 | ARAF | 0.52186905 |
| 79 | DAPK3 | 0.49317522 |
| 80 | BUB1 | 0.48664515 |
| 81 | LCK | 0.48662967 |
| 82 | MATK | 0.48569983 |
| 83 | PTK2B | 0.47730680 |
| 84 | CSNK2A1 | 0.43238056 |
| 85 | PLK4 | 0.42015555 |
| 86 | AURKA | 0.41252771 |
| 87 | MYLK | 0.41246089 |
| 88 | CSNK1A1 | 0.40777822 |
| 89 | PRKACA | 0.40038146 |
| 90 | GRK5 | 0.39874967 |
| 91 | BTK | 0.38480931 |
| 92 | MUSK | 0.36885028 |
| 93 | PIK3CG | 0.35821567 |
| 94 | ABL1 | 0.35784197 |
| 95 | JAK3 | 0.35069311 |
| 96 | CAMK2A | 0.34810807 |
| 97 | DYRK1B | 0.34534498 |
| 98 | PIM1 | 0.33745795 |
| 99 | ABL2 | 0.33605898 |
| 100 | IGF1R | 0.31781030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.87596457 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.47794111 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.18153378 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.93410266 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.82352118 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.62126979 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.48350008 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.47233527 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.37990202 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.31718367 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.28758872 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.25569845 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.05871708 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 1.97293290 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 1.94016850 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.93465137 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 1.82568944 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77428453 |
| 19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.70782542 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.66151329 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.62736201 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55850083 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.53858585 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.48416645 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41535248 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.39076516 |
| 27 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.35869682 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30403569 |
| 29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.22954664 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.21504924 |
| 31 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.20450535 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16621650 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.13019160 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10746640 |
| 35 | RNA degradation_Homo sapiens_hsa03018 | 1.10355472 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.09543888 |
| 37 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.05763955 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.04793905 |
| 39 | Ribosome_Homo sapiens_hsa03010 | 1.02869461 |
| 40 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.98851801 |
| 41 | Basal transcription factors_Homo sapiens_hsa03022 | 0.95300707 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.93245107 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92230799 |
| 44 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.91333919 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91298226 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90183061 |
| 47 | Base excision repair_Homo sapiens_hsa03410 | 0.88987507 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85712607 |
| 49 | Homologous recombination_Homo sapiens_hsa03440 | 0.84240062 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.82085695 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.81590151 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81040136 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78693707 |
| 54 | Purine metabolism_Homo sapiens_hsa00230 | 0.77994371 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.75691224 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75491427 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74838700 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.74271722 |
| 59 | Nicotine addiction_Homo sapiens_hsa05033 | 0.74183687 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71843939 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70364137 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69993793 |
| 63 | Alcoholism_Homo sapiens_hsa05034 | 0.66515514 |
| 64 | Spliceosome_Homo sapiens_hsa03040 | 0.66387788 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66340313 |
| 66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.65941060 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65478740 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.65118782 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64390746 |
| 70 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.61378721 |
| 71 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60492412 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59800532 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59544723 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58014826 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55095872 |
| 76 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54773677 |
| 77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.54071936 |
| 78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53418733 |
| 79 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52646764 |
| 80 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.51888809 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51077064 |
| 82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48943217 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48167816 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47410805 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.47181341 |
| 86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45453633 |
| 87 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44249988 |
| 88 | Morphine addiction_Homo sapiens_hsa05032 | 0.44245757 |
| 89 | Taste transduction_Homo sapiens_hsa04742 | 0.43718466 |
| 90 | RNA transport_Homo sapiens_hsa03013 | 0.42894298 |
| 91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37459943 |
| 92 | Tuberculosis_Homo sapiens_hsa05152 | 0.35791428 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35153939 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34950761 |
| 95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.29393985 |
| 96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.29182631 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.29177247 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.28458060 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.26837705 |
| 100 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.26049072 |

